Cartesian Therapeutics, Inc. (RNAC)

NASDAQ: RNAC · IEX Real-Time Price · USD

15.77

-8.50 (-35.02%)

At close: Jul 2, 2024, 4:00 PM

16.24

+0.47 (2.98%)

After-hours: Jul 2, 2024, 7:48 PM EDT

Cartesian Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Net Income	-219.71	35.38	-25.69	-68.88	-55.35	Upgrade
Depreciation & Amortization	2.6	2.62	2.37	1.86	2.03	Upgrade
Share-Based Compensation	22.52	11.19	7.72	5.42	5.16	Upgrade
Other Operating Activities	143.43	-80.83	-44.79	96.47	-3.27	Upgrade
Operating Cash Flow	-51.16	-31.63	-60.38	34.88	-51.44	Upgrade
Capital Expenditures	-0.21	-1.2	-1.09	-0.74	0.08	Upgrade
Acquisitions	6.56	0	0	0	0	Upgrade
Change in Investments	28.25	-13.8	-16.06	0	0.15	Upgrade
Investing Cash Flow	34.61	-15	-17.14	-0.74	0.23	Upgrade
Share Issuance / Repurchase	0.23	39.33	52.9	13.73	107.84	Upgrade
Debt Issued / Paid	-27.46	-0.11	0	5.42	-2.8	Upgrade
Other Financing Activities	14.08	-	-	-4.72	-	Upgrade
Financing Cash Flow	-13.15	39.22	52.9	14.43	105.04	Upgrade
Exchange Rate Effect	-0.05	0.02	-0	-0.06	0.03	Upgrade
Net Cash Flow	-29.75	-7.4	-24.63	48.51	53.87	Upgrade
Free Cash Flow	-51.37	-32.83	-61.47	34.14	-51.36	Upgrade
Free Cash Flow Margin	-197.53%	-29.64%	-72.25%	205.70%	-769.21%	Upgrade
Free Cash Flow Per Share	-9.94	-6.80	-16.13	10.12	-33.83	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).